Berkeley Lights, Inc. (BLI)

NASDAQ: BLI · IEX Real-Time Price · USD
2.43
+0.07 (2.97%)
Feb 3, 2023, 4:00 PM EST - Market closed
2.97%
Market Cap 167.34M
Revenue (ttm) 83.94M
Net Income (ttm) -86.47M
Shares Out 68.86M
EPS (ttm) -1.29
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 802,154
Open 2.30
Previous Close 2.36
Day's Range 2.27 - 2.51
52-Week Range 1.83 - 9.03
Beta 1.45
Analysts Buy
Price Target 10.46 (+330.45%)
Earnings Date Feb 23, 2023

About BLI

Berkeley Lights, Inc., a digital cell biology company, focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software. It serves in North America, the Asia Pacific, and Europe. Berkeley Lights, Inc. was incorporated in 2011 and is headquartered in Emeryville, California. [Read more]

Industry Biotechnology
Sector Healthcare
IPO Date Jul 17, 2020
Employees 293
Stock Exchange NASDAQ
Ticker Symbol BLI
Full Company Profile

Financial Performance

In 2021, BLI's revenue was $85.39 million, an increase of 32.79% compared to the previous year's $64.30 million. Losses were -$71.72 million, 72.5% more than in 2020.

Financial Statements

Analyst Forecast

According to 11 analysts, the average rating for BLI stock is "Buy." The 12-month stock price forecast is $10.46, which is an increase of 330.45% from the latest price.

Price Target
$10.46
(330.45% upside)
Analyst Consensus: Buy
Stock Forecasts

News

SHAREHOLDER ALERT: Weiss Law Investigates IsoPlexis Corporation

NEW YORK , Feb. 3, 2023 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of IsoPlexis Corporation ("IsoPlexis" or th...

Other symbols: ISO
2 days ago - PRNewsWire

Berkeley Lights Reports Preliminary Full Year 2022 Revenue Results

EMERYVILLE, Calif. , Jan. 9, 2023 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today announced preliminary unaudited revenue results for the full year ended Dece...

3 weeks ago - PRNewsWire

Berkeley Lights Launches Beacon Select™, A New Optofluidic System For Cell Line Development

New, two-chip, single-cell optofluidic system ideal for small- to mid-sized biopharma & CDMOs/CROs to affordably gain access to the Beacon® technology and cell line development-specific applications E...

3 weeks ago - PRNewsWire

Berkeley Lights to Participate in the 41st Annual J.P. Morgan Healthcare Conference

EMERYVILLE, Calif. , Jan. 3, 2023 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today announced the Company will be participating in the upcoming 41st Annual J.P.

1 month ago - PRNewsWire

ISOPLEXIS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of IsoPlexis Corporation - ISO

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of IsoPlexis Corp...

Other symbols: ISO
1 month ago - Business Wire

BLI STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Merger of Berkeley Lights, Inc. Is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Berkeley Lights, Inc. (NASDAQ: BLI) and Isoplexis Corporation is fair to Berkeley sha...

1 month ago - Business Wire

Berkeley Lights to Showcase its New Beacon® System Workflow to Access Broad B Cell Diversity to Rapidly Identify High-Value Rabbit Monoclonal Antibodies at 2022 Antibody Engineering & Therapeutics Conference

EMERYVILLE, Calif. , Nov. 30, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced its participation at the upcoming Antibody Engineering & Thera...

2 months ago - PRNewsWire

Berkeley Lights Accelerating Antibody Discovery with Launch of Rabbit Memory B Cell Workflow

Enables access to a broad range of biodiversity to find unique antibodies against challenging targets EMERYVILLE, Calif. , Nov. 18, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (NASDAQ: BLI), a leader i...

2 months ago - PRNewsWire

Monash University Implements Antibody Discovery Application by Utilizing the Berkeley Lights Beacon® Platform

EMERYVILLE, Calif. and MELBOURNE, Australia , Nov. 9, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced Monash University, one of Australia's ...

3 months ago - PRNewsWire

Berkeley Lights, Inc. (BLI) Reports Q3 Loss, Misses Revenue Estimates

Berkeley Lights, Inc. (BLI) delivered earnings and revenue surprises of -18.52% and 1.22%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stoc...

3 months ago - Zacks Investment Research

Berkeley Lights Reports Third Quarter 2022 Financial Results

EMERYVILLE, Calif. , Nov. 8, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today reported financial results for the quarter ended September 30, 2022.

3 months ago - PRNewsWire

Berkeley Lights to Host Upcoming Investor Day

EMERYVILLE, Calif. , Nov. 4, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced it will host its 2022 Investor Day on Friday, November 18 start...

3 months ago - PRNewsWire

Berkeley Lights to Report Third Quarter 2022 Financial Results on November 8, 2022

EMERYVILLE, Calif. , Oct. 18, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that the Company will be reporting financial results for the t...

3 months ago - PRNewsWire

Berkeley Lights to Participate in the BioProcess International 2022 Conference

Company to present on its Bispecifics Heterodimer Assay and Custom Productivity Assay for the Opto ®  Cell Line Development workflow GSK Vaccines, Rockville to present on their successful implementati...

4 months ago - PRNewsWire

Berkeley Lights Announces Appointment of Scott Chaplin as Chief Legal Officer

EMERYVILLE, Calif. , Sept. 19, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that Scott Chaplin has been named the Company's chief legal o...

4 months ago - PRNewsWire

Berkeley Lights, Inc. (BLI) Reports Q2 Loss, Misses Revenue Estimates

Berkeley Lights, Inc. (BLI) delivered earnings and revenue surprises of -26.67% and 14.56%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

Berkeley Lights Reports Second Quarter 2022 Financial Results

Company outlines near-term strategic plan to generate positive operating cashflow by early 2025 EMERYVILLE, Calif. , Aug. 9, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digit...

6 months ago - PRNewsWire

Berkeley Lights and the Jaime Leandro Foundation Announce the Discovery, Functional Characterization, and Recovery of a Patient-Derived T cell Receptor Sequence Against a Cancer Neoantigen

EMERYVILLE, Calif. , Aug. 4, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and the Jaime Leandro Foundation for Therapeutic Cancer Vaccines (JLF), today a...

6 months ago - PRNewsWire

Berkeley Lights to Participate in the Cambridge Healthtech Institute's 14th Annual Bioprocessing Summit Conference

Presentation to feature the Company's soon-to-be launched bispecific and custom productivity assay for the Opto® Cell Line Development workflow EMERYVILLE, Calif. , Aug. 3, 2022 /PRNewswire/ -- Berkel...

6 months ago - PRNewsWire

Berkeley Lights Announces Appointment of Dr. Rolando Brawer as Executive Vice President, Strategy & Corporate Development

EMERYVILLE, Calif. , Aug. 1, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that Rolando Brawer, Ph.D.

6 months ago - PRNewsWire

Berkeley Lights and Aanika BioSciences Reach Strategic Partnership Milestone By Identifying A Commercially Viable Antimicrobial Peptide

Using Berkeley Lights' high-throughput, functional screening service, Aanika BioSciences will now rapidly commercialize the propriety peptide to help improve and protect global food system EMERYVILLE,...

6 months ago - PRNewsWire

Berkeley Lights Announces Mehul Joshi as New Chief Financial Officer

EMERYVILLE, Calif. , July 25, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that Mehul Joshi has been named chief financial officer (CFO),...

6 months ago - PRNewsWire

Berkeley Lights to Report Second Quarter 2022 Financial Results on August 9, 2022

EMERYVILLE, Calif. , July 21, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that the Company will be reporting financial results for the s...

7 months ago - PRNewsWire

Berkeley Lights to Participate at the 27th European Society for Animal Cell Technology Meeting

Lonza and Edinburgh Genome Foundry to present their high-throughput single-cell screening workflow use cases using the Beacon® Platform Lonza and Edinburgh Genome Foundry to present their high-through...

8 months ago - GlobeNewsWire

Curia Adopts the Berkeley Lights Platform to Expand its Antibody Discovery Capabilities

EMERYVILLE, Calif. & ALBANY, N.Y.--(BUSINESS WIRE)-- #AMRI--Curia now provides a comprehensive portfolio of state-of-the-art technologies and experience for rapid progression of client antibody progra...

8 months ago - Business Wire